4Sirol M, Fuster V, Fayad ZA, et al, Plaque Imaging and Characterization Using Magnetic Resonance Imaging: Towards Molecular Assessment [ J ]. Curr Mol Med, 2006, 6(5) :541 -548.
4Flaeke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation,2001, 104 : 1280-1285.
5Winter PM, Caruthers SD, Yu X, et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med, 2003, 50:411-416.
6Botnar RM, Perez AS, Witte S, et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation, 2004, 109: 2023- 2029.
7Sirol M, Aguinaldo JGS, Graham PB, et al. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis .2005.182,79-85.
8Corti R, Osende JI, Fayad ZA, et al. In vivo non-invasive detection and age definition of arterial thrombus by MRI. J Am Coil Cardiol, 2002, 39 : 1366-1373.
9Botnar RM, Buecker A, Wiethoff A J, et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation, 2004, 110 : 1463-1466.
10Sirol M, Fuster V, Badimon J J, et al. Chronic thrombus detectionwith in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation,2005, 112 : 1594-1600.
